Prognostic Significance of Ezrin Expression in Liposarcoma
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background : Ezrin has been reported to be involved in the metastasis of solid tumors in both an animal model and clinical trials. However, questions remains as to whether an ezrin expression is an independent predictor of the event-free survival of liposarcoma patients. Methods : We analyzed 85 liposarcoma patients without metastasis at the time of presentation. We performed immunohistochemistry with anti-ezrin antibody, and we analyzed the association of an ezrin expression with the clinicopathological variables and event-free survival. Results : Twenty-nine patients (34.1%) showed an ezrin expression. Among the 30 low-grade liposarcoma patients, only one patient showed ezrin positivity. The patients who had an ezrin expression were found to be at a significantly increased risk for metastasis compared with the patients who had no ezrin expression (risk ratio: 3.4, 95% confidence interval: 1.3-9.1). The 10-year metastasis-free survival rate was 26.9% for the patients with an ezrin expression and 86.7% for the patients without an ezrin expression. The ezrin expression rate increased with an advanced tumor grade and stage. Conclusions : An ezrin expression is an independent predictor of distant metastasis for liposarcoma. Thus, ezrin has the potential to provide additional prognostic information and to be a novel target for the development of new adjuvant therapies for treating the patients who suffer from liposarcoma.
Abstract
Background : Ezrin has been reported to be involved in the metastasis of solid tumors in both an animal model and clinical trials. However, questions remains as to whether an ezrin expression is an independent predictor of the event-free survival of liposarcoma patients. Methods : We analyzed 85 liposarcoma patients without metastasis at the time of presentation. We performed immunohistochemistry with anti-ezrin antibody, and we analyzed the association of an ezrin expression with the clinicopathological variables and event-free survival. Results : Twenty-nine patients (34.1%) showed an ezrin expression. Among the 30 low-grade liposarcoma patients, only one patient showed ezrin positivity. The patients who had an ezrin expression were found to be at a significantly increased risk for metastasis compared with the patients who had no ezrin expression (risk ratio: 3.4, 95% confidence interval: 1.3-9.1). The 10-year metastasis-free survival rate was 26.9% for the patients with an ezrin expression and 86.7% for the patients without an ezrin expression. The ezrin expression rate increased with an advanced tumor grade and stage. Conclusions : An ezrin expression is an independent predictor of distant metastasis for liposarcoma. Thus, ezrin has the potential to provide additional prognostic information and to be a novel target for the development of new adjuvant therapies for treating the patients who suffer from liposarcoma.
참고문헌 (14)
- Weiss SW, "Enzinger and Weiss’s soft tissue tumors. 4th ed" (2001), Mosby
- Gebhard S, "Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases", Am J Surg Pathol, 26, pp.601~616 (2002)
- Pearlstone DB, "Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up", Cancer, 85, pp.85~92 (1999)
- Greene FL, "American Joint Committee on Cancer: cancer staging manual. 6th ed" (2002), Springer
- Smith TA, "Myxoid", round cell liposarcoma of the extremities: a clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma, 1996, pp.20, 171~180
- Khanna C, "The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis", Nat Med, 10, pp.182~186 (2004)
- Hunter KW, "Ezrin, a key component in tumor metastasis", Trends Mol Med, 10, pp.201~204 (2004)
- Weng WH, "Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas", Clin Cancer Res, 11, pp.6198~6204 (2005)
- Spillane AJ, "Myxoid liposarcoma: the frequency and the natural history of nonpulmonary soft tissue metas tases", Ann Surg Oncol, 6, pp.389~394 (1999)
- Chang HR, "Multifactorial analysis of survival in primary extremity liposarcoma", World J Surg, 14, pp.610~618 (1990)
- Eilber FC, "The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma", Ann Surg, 240, pp.686~695 (2004)
- Zagars GK, "Liposarcoma: outcome and prognostic factors following conservation surgery and radiation therapy", Int J Radiat Oncol Biol Phys, 36, pp.311~319 (1996)
- Jones RL, "Differential sensitivity of liposarcoma subtypes to chemotherapy", Eur J Cancer, 41, pp.2853~2860 (2005)
- Wan X, "Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma", Cancer Res, 65, pp.2406~2411 (2005)